Literature DB >> 19383940

Multiple congenital malformations of Wolf-Hirschhorn syndrome are recapitulated in Fgfrl1 null mice.

Catarina Catela1, Daniel Bilbao-Cortes, Esfir Slonimsky, Paschalis Kratsios, Nadia Rosenthal, Pascal Te Welscher.   

Abstract

Wolf-Hirschhorn syndrome (WHS) is caused by deletions in the short arm of chromosome 4 (4p) and occurs in about one per 20,000 births. Patients with WHS display a set of highly variable characteristics including craniofacial dysgenesis, mental retardation, speech problems, congenital heart defects, short stature and a variety of skeletal anomalies. Analysis of patients with 4p deletions has identified two WHS critical regions (WHSCRs); however, deletions targeting mouse WHSCRs do not recapitulate the classical WHS defects, and the genes contributing to WHS have not been conclusively established. Recently, the human FGFRL1 gene, encoding a putative fibroblast growth factor (FGF) decoy receptor, has been implicated in the craniofacial phenotype of a WHS patient. Here, we report that targeted deletion of the mouse Fgfrl1 gene recapitulates a broad array of WHS phenotypes, including abnormal craniofacial development, axial and appendicular skeletal anomalies, and congenital heart defects. Fgfrl1 null mutants also display a transient foetal anaemia and a fully penetrant diaphragm defect, causing prenatal and perinatal lethality. Together, these data support a wider role for Fgfrl1 in development, implicate FGFRL1 insufficiency in WHS, and provide a novel animal model to dissect the complex aetiology of this human disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19383940      PMCID: PMC2675798          DOI: 10.1242/dmm.002287

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  47 in total

1.  The cell surface receptor FGFRL1 forms constitutive dimers that promote cell adhesion.

Authors:  Thorsten Rieckmann; Ivana Kotevic; Beat Trueb
Journal:  Exp Cell Res       Date:  2007-11-12       Impact factor: 3.905

2.  Strain-dependent perinatal lethality of Ovol1-deficient mice and identification of Ovol2 as a downstream target of Ovol1 in skin epidermis.

Authors:  Andy Teng; Mahalakshmi Nair; Julie Wells; Julia A Segre; Xing Dai
Journal:  Biochim Biophys Acta       Date:  2006-09-12

3.  Fgfrl1, a fibroblast growth factor receptor-like gene, is found in the cephalochordate Branchiostoma floridae but not in the urochordate Ciona intestinalis.

Authors:  Michael Beyeler; Beat Trueb
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2006-06-17       Impact factor: 2.231

4.  Fibroblast growth factor expression in the postnatal growth plate.

Authors:  Jacob E Lazarus; Anita Hegde; Anenisia C Andrade; Ola Nilsson; Jeffrey Baron
Journal:  Bone       Date:  2006-12-13       Impact factor: 4.398

5.  Genotype-phenotype correlation in 21 patients with Wolf-Hirschhorn syndrome using high resolution array comparative genome hybridisation (CGH).

Authors:  N M C Maas; G Van Buggenhout; F Hannes; B Thienpont; D Sanlaville; K Kok; A Midro; J Andrieux; B-M Anderlid; J Schoumans; R Hordijk; K Devriendt; J-P Fryns; J R Vermeesch
Journal:  J Med Genet       Date:  2007-09-14       Impact factor: 6.318

6.  Mice with a targeted disruption of the Fgfrl1 gene die at birth due to alterations in the diaphragm.

Authors:  Stefan Baertschi; Lei Zhuang; Beat Trueb
Journal:  FEBS J       Date:  2007-11-06       Impact factor: 5.542

7.  Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure.

Authors:  Jeannette Connerney; Viktoria Andreeva; Yael Leshem; Miguel A Mercado; Karen Dowell; Xuehei Yang; Volkhard Lindner; Robert E Friesel; Douglas B Spicer
Journal:  Dev Biol       Date:  2008-04-08       Impact factor: 3.582

8.  Pathogenic significance of deletions distal to the currently described Wolf-Hirschhorn syndrome critical regions on 4p16.3.

Authors:  Sarah T South; Femke Hannes; Gene S Fisch; Joris Robert Vermeesch; Marcella Zollino
Journal:  Am J Med Genet C Semin Med Genet       Date:  2008-11-15       Impact factor: 3.908

9.  Wolf-Hirschhorn syndrome facial dysmorphic features in a patient with a terminal 4p16.3 deletion telomeric to the WHSCR and WHSCR 2 regions.

Authors:  Hannelie Engbers; Jasper J van der Smagt; Ruben van 't Slot; Joris R Vermeesch; Ron Hochstenbach; Martin Poot
Journal:  Eur J Hum Genet       Date:  2008-10-01       Impact factor: 4.246

10.  Expression of FGFRL1, a novel fibroblast growth factor receptor, during embryonic development.

Authors:  Beat Trueb; Sara Taeschler
Journal:  Int J Mol Med       Date:  2006-04       Impact factor: 4.101

View more
  35 in total

1.  Rapid fusion and syncytium formation of heterologous cells upon expression of the FGFRL1 receptor.

Authors:  Florian Steinberg; Simon D Gerber; Thorsten Rieckmann; Beat Trueb
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

2.  Hectd1 is required for development of the junctional zone of the placenta.

Authors:  Anjali A Sarkar; Samer J Nuwayhid; Thomas Maynard; Frederick Ghandchi; Jonathon T Hill; Anthony S Lamantia; Irene E Zohn
Journal:  Dev Biol       Date:  2014-05-20       Impact factor: 3.582

3.  Identification of a novel FGFRL1 MicroRNA target site polymorphism for bone mineral density in meta-analyses of genome-wide association studies.

Authors:  Tianhua Niu; Ning Liu; Ming Zhao; Guie Xie; Lei Zhang; Jian Li; Yu-Fang Pei; Hui Shen; Xiaoying Fu; Hao He; Shan Lu; Xiang-Ding Chen; Li-Jun Tan; Tie-Lin Yang; Yan Guo; Paul J Leo; Emma L Duncan; Jie Shen; Yan-Fang Guo; Geoffrey C Nicholson; Richard L Prince; John A Eisman; Graeme Jones; Philip N Sambrook; Xiang Hu; Partha M Das; Qing Tian; Xue-Zhen Zhu; Christopher J Papasian; Matthew A Brown; André G Uitterlinden; Yu-Ping Wang; Shuanglin Xiang; Hong-Wen Deng
Journal:  Hum Mol Genet       Date:  2015-05-04       Impact factor: 6.150

4.  Prioritization of Candidate Genes for Congenital Diaphragmatic Hernia in a Critical Region on Chromosome 4p16 using a Machine-Learning Algorithm.

Authors:  Danielle A Callaway; Ian M Campbell; Samantha R Stover; Andres Hernandez-Garcia; Shalini N Jhangiani; Jaya Punetha; Ingrid S Paine; Jennifer E Posey; Donna Muzny; Kevin P Lally; James R Lupski; Chad A Shaw; Caraciolo J Fernandes; Daryl A Scott
Journal:  J Pediatr Genet       Date:  2018-05-30

Review 5.  The influence of genetics in congenital diaphragmatic hernia.

Authors:  Lan Yu; Rebecca R Hernan; Julia Wynn; Wendy K Chung
Journal:  Semin Perinatol       Date:  2019-08-01       Impact factor: 3.300

6.  Partial Monosomy 4p and Trisomy 12q due to a t(4;12)(p16.3;q24.31) Familial Translocation in Two Cousins.

Authors:  Tatiana Mozer Joaquim; Carlos H Paiva Grangeiro; Flávia Gaona de Oliveira Gennaro; Alexandra Galvão Gomes; Jeremy A Squire; Lucia R Martelli
Journal:  Mol Syndromol       Date:  2019-07-27

7.  Comparison of the receptor FGFRL1 from sea urchins and humans illustrates evolution of a zinc binding motif in the intracellular domain.

Authors:  Lei Zhuang; Andrei V Karotki; Philip Bruecker; Beat Trueb
Journal:  BMC Biochem       Date:  2009-12-18       Impact factor: 4.059

8.  The FGFRL1 receptor is shed from cell membranes, binds fibroblast growth factors (FGFs), and antagonizes FGF signaling in Xenopus embryos.

Authors:  Florian Steinberg; Lei Zhuang; Michael Beyeler; Roland E Kälin; Primus E Mullis; André W Brändli; Beat Trueb
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

9.  Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf-Hirschhorn Syndrome.

Authors:  Erica F Andersen; John C Carey; Dawn L Earl; Deyanira Corzo; Michael Suttie; Peter Hammond; Sarah T South
Journal:  Eur J Hum Genet       Date:  2013-08-21       Impact factor: 4.246

10.  FGFRL1 is a neglected putative actor of the FGF signalling pathway present in all major metazoan phyla.

Authors:  Stephanie Bertrand; Ildiko Somorjai; Jordi Garcia-Fernandez; Thomas Lamonerie; Hector Escriva
Journal:  BMC Evol Biol       Date:  2009-09-09       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.